tiprankstipranks
BioVaxys Completes First Private Placement Tranche
Company Announcements

BioVaxys Completes First Private Placement Tranche

Story Highlights

BioVaxys Technology (TSE:BIOV) has released an update.

Don't Miss our Black Friday Offers:

BioVaxys Technology Corp. has successfully completed the first tranche of its non-brokered private placement, raising $350,000 through the issuance of 7 million units and settling $733,600 in debt with 14.672 million shares. The funds are earmarked for general working capital and to advance the company’s business following its acquisition of a portfolio of immunological assets from IMV Inc.

For further insights into TSE:BIOV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskBioVaxys and SpayVac Boost Vaccine Production Capacity
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Joins US Vaccine Development Consortium
TipRanks Canadian Auto-Generated NewsdeskBioVaxys Advances in Drug Delivery Market
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App